<DOC>
	<DOCNO>NCT00862628</DOCNO>
	<brief_summary>The purpose study evaluate efficacy rebamipide NSAID-induced small-intestinal injury .</brief_summary>
	<brief_title>The Effect Rebamipide Non-steroidal Anti-inflammatory Drugs ( NSAID ) - Induced Small-intestinal Injuries</brief_title>
	<detailed_description />
	<mesh_term>Anti-Inflammatory Agents , Non-Steroidal</mesh_term>
	<mesh_term>Rebamipide</mesh_term>
	<criteria>Written inform consent 20 85 year age RA , OA , low back pain No change drug 3 month Under 5 mg corticosteroid use CRP &lt; 1mg/dl Smallintestinal mucosal injuries one Hemoglobin level normal range Known suspect smallbowel disease , include Crohn 's disease seronegative arthritis Prostaglandins , metronidazole salazosulfapyridine Can swallow Eith pacemaker After gastrointestinal operation Serious concomitant cardiovascular , endocrine , gastrointestinal ( include symptom ileus ) , neurologic , psychiatric , renal , respiratory disease . Taking rebamipide one week Any condition investigator feel would interfere data interpretation create risk .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>September 2009</verification_date>
</DOC>